Researchers at MIT and Scripps have reported that a DNA-based virus-like particle vaccine has generated markedly higher ...

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...

Wits University says it is developing its own engineered virus-like particle systems to boost vaccine production in South Africa and beyond.

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...

The new foot-and-mouth disease vaccine developed by researchers at Diamond Light Source is projected to deliver over $1.3 billion in annual benefits and transform global livestock resilience. Science ...